Boston Sci Sales Returning to Pre-Pandemic Levels
The Marlborough, MA-based company posted net sales of $3.08 billion for 2Q21 – a 53.6% increase when compared to the same period last year.
The Marlborough, MA-based company posted net sales of $3.08 billion for 2Q21 – a 53.6% increase when compared to the same period last year.
Collaboration Aims to Explore Benefits of Remote Monitoring of Patients Pre- and Post-Ablation
Evren Technologies this week announced that it received FDA breakthrough device designation for its Phoenix […]
Intersect ENT today announced that it has commercially launched its VenSure balloon sinus dilation system […]
BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed […]
3M (NYSE:MMM) shares ticked up before hours this morning on second-quarter results that beat the consensus […]
Race, in combination with other factors, predicted how quickly individuals with stroke got to care […]
Luxsonic’s virtual reality suite, the SieVRt, landed clearance from Health Canada in order to be used in diagnostic radiology.
At the Houston Methodist Neurological Institute, researchers have developed a device that generates a magnetic […]
In the year and a half since its purchase by Illumina was thwarted by the […]
New Mountain Capital’s ILC Dover today announced that it has reached a definitive agreement to […]
Medtronic today announced that it has launched its Prevail drug-coated balloon catheter in Europe. Dublin-based […]
Medical device startup Fisher Wallace Laboratories has been named one of “5 Health-Tech Startups to Watch […]
Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA).
The biggest medtech news of the week, in one minute or less.
The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials.
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, […]
J&J Vision today announced that it has launched its Veritas Vision System for cataract surgery. […]
Royal Philips (NYSE:PHG) announced today that it received FDA breakthrough device designation for its laser-assisted IVC […]
While the robotic surgery leader is eyeing the delta variant for potential to curb demand, the company raised its forecast for procedure growth this year. However, the outlook does not reflect significant disruptions.
NeuroMetrix (NSDQ:NURO) today announced that its Quell device has received FDA breakthrough designation for treating fibromyalgia […]
The Franklin Lakes, NJ-based company said it has acquired Velana Vascular, a company that has needle-free technology, which enables high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines.
The new system lets clinicians record and share videos – and communicate during an operation.
Endologix announced today that the FDA granted breakthrough device designation for its Chimney endovascular aneurysm sealing […]
Dive Brief: After a sluggish first quarter, investment in medical device makers roared back in […]
Panakès has raised a €150 million ($177 million) fund that will extend its focus beyond medtech […]
Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease.
100Plus, a California medtech company, created a suite of remote patient monitoring technologies. These include […]
French artificial heart maker Carmat recently reported the first U.S. implantation of its bioprosthetic artificial […]
Researchers have developed the first-ever transient pacemaker — a wireless, battery-free, fully implantable pacing device […]
Santa Clara, CA-based Ancora Heart is developing the AccuCinch System, a device-therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care.
Nevro (NYSE:NVRO) announced today that it received FDA approval for its Senza system for treating chronic […]
Intuitive and J&J are set to report results this week that will shed light on the recovery of elective procedures, while Abbott will provide insights into the drop in coronavirus test demand, serving as an indication of rivals’ performance.
The medtech industry’s steady growth provided optimism in recent weeks, but an unforeseen leap sees […]
As we enter what may be the “new normal,” Dexcom’s CEO bets the company can […]
Swift Medical, a startup building an app to help nurses identify and better care for wounds, recently raised $35 million in funding.
The biggest medtech news of the week, in one minute or less.
Medtech M&A took off in the first half of 2021, already eclipsing the number of […]
The FDA has yet to approve a therapy for memory loss. Nia Therapeutics is developing a medical device that stimulates the brain to bring it back to a “good memory state,” and it was judged the winner in the life sciences track of the INVEST Precision Medicine Pitch Perfect Competition.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.